ADVFN US – Market Content Editor
-
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission, PDUFA Date of March 25, 2027
Unicycive Therapeutics, Inc. (Nasdaq: UNCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company’s investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.
-
Tech Rally Lifts Wall Street as SpaceX Surges
U.S. stocks finished higher on Wednesday, with technology shares leading the way as investors cheered strong quarterly results from SpaceX and positioned ahead of earnings from Tesla and Meta after the closing bell. All three major averages gained despite a jump in oil prices tied to an attack on a Saudi Aramco field, suggesting investors…
-
Software stocks gain as market warning signals flash
Bruce Campbell examines the rotation from semiconductors into software, weakening US banking stocks and fresh warning signals across equity markets.
-
Manufacturing Progress Gives INmune Bio a Clearer UK Filing Path for Ebstrocel
INmune Bio (NASDAQ:INMB) is advancing its European commercialization strategy for Ebstrocel, leveraging chemistry, manufacturing, and controls (CMC) progress to streamline its regulatory timeline and accelerate potential entry into the UK market. By submitting its final pre-marketing authorization application (pre-MAA) package to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the biotechnology company confirmed a…
-
Why Is Netflix Stock Falling Over 5% Despite Beating Third-Quarter Earnings Estimates?
Why did Netflix shares decline in pre-market trading? Netflix (NASDAQ:NFLX) shares fell more than 5% in pre-market trading after the streaming company issued fourth-quarter revenue guidance below Wall Street expectations, despite reporting third-quarter earnings above analysts’ forecasts. The company also reduced its annual advertising revenue outlook, citing delays in the introduction of certain advertising products.…
-
How Is NVIDIA Expanding AI-Powered Telecom Networks Following T-Mobile’s First AI-RAN Call?
What did T-Mobile and NVIDIA announce at GTC Berlin? NVIDIA (NASDAQ:NVDA) announced at its GTC Berlin event that T-Mobile US (NASDAQ:TMUS) had completed what the companies described as the world’s first AI Radio Access Network (AI-RAN) call on a commercial mobile network. The demonstration took place in Bellevue, Washington, in collaboration with NVIDIA and Nokia…
-
Why Is AT&T Stock Falling Despite Beating Third-Quarter Earnings Estimates?
Why did AT&T shares decline in pre-market trading? AT&T Inc. (NYSE:T) shares fell 3.3% in pre-market trading on Wednesday following the release of its third-quarter 2026 financial results, despite the telecommunications company reporting earnings and revenue above Wall Street expectations. The company also increased its full-year adjusted earnings guidance and maintained its free cash flow…
-
Why Is CrowdStrike Stock Rising Following Its Expanded NVIDIA AI Security Partnership?
Why did CrowdStrike shares increase on Wednesday? CrowdStrike (NASDAQ:CRWD) shares rose 1.5% on Wednesday following an announcement that the cybersecurity company had expanded its collaboration with NVIDIA (NASDAQ:NVDA) to develop additional security capabilities for artificial intelligence systems. The agreement focuses on extending AI security protections beyond conventional software-based monitoring to include controls integrated directly into…
-
AST SpaceMobile Targets Initial Satellite Broadband Coverage in Five Countries by End of 2026
AST SpaceMobile (NASDAQ:ASTS) is preparing to introduce initial intermittent satellite-based cellular broadband coverage in five countries before the end of 2026, according to a research note from Bank of America. The planned service would initially cover selected areas of the United States, Canada, Japan, the United Kingdom and Saudi Arabia, marking a further stage in…
-
Elevance Health Shares Rise as Third-Quarter Earnings Beat Estimates and 2026 Guidance Increases
Elevance Health Inc. (NYSE:ELV) shares advanced 1.1% following the release of its third-quarter 2026 financial results on Wednesday, after the US health insurance company reported earnings and revenue above analysts’ expectations and raised its full-year outlook. The company posted adjusted earnings per share of $6.99, exceeding the analyst consensus estimate of $4.70. Third-quarter operating revenue…